Baseline tumor 18F-FDG uptake and modifications after 2 cycles of neoadjuvant chemotherapy are prognostic of outcome in ER+/HER2− breast cancer

D Groheux, A Sanna, M Majdoub… - Journal of Nuclear …, 2015 - Soc Nuclear Med
This study investigated whether 18F-FDG PET/CT performed at baseline and during
neoadjuvant chemotherapy (NAC) was able to early depict estrogen receptor …

[HTML][HTML] Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes

O Humbert, A Berriolo-Riedinger, JM Riedinger… - Annals of oncology, 2012 - Elsevier
Background The aim of this study is to evaluate the impact of the different breast cancer
subtypes on the tumor 18 F-FDG uptake at baseline and on its changes after the first course …

Prognostic role of early and end-of-neoadjuvant treatment 18F-FDG PET/CT in patients with breast cancer

AMG Vicente, M Amo-Salas, FR Calatayud… - Clinical Nuclear …, 2016 - journals.lww.com
Aim To determine the use of early and final treatment 18 F-FDG PET/CT in the prediction of
response to neoadjuvant chemotherapy (NAC) and its role in the prognosis of patients with …

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

BB Koolen, KE Pengel, J Wesseling, WV Vogel… - The Breast, 2013 - Elsevier
Background Response monitoring with MRI during neoadjuvant chemotherapy (NAC) in
breast cancer is promising, but knowledge of breast cancer subtype is essential. The aim of …

The prognostic impact of early change in 18F-FDG PET SUV after neoadjuvant chemotherapy in patients with locally advanced breast cancer

HW Lee, HM Lee, SE Choi, H Yoo… - Journal of Nuclear …, 2016 - Soc Nuclear Med
SUV, which is an indicator of the degree of glucose uptake in 18F-FDG PET, can be applied
as a prognostic factor in various malignant tumors. We investigated the prognostic impact of …

Role of 18F-PET/CT in predicting prognosis of patients with breast cancer after neoadjuvant chemotherapy

E Akimoto, T Kadoya, K Kajitani, A Emi… - Clinical Breast …, 2018 - Elsevier
Background Breast cancer can be assessed preoperatively and postoperatively using 18 F-
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …

[HTML][HTML] 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast …

J Cheng, Y Wang, M Mo, X Bao, Y Zhang, G Liu… - Oncotarget, 2015 - ncbi.nlm.nih.gov
The aim of this prospective study was to assess the ability of 18F-fluorodeoxyglucose (18
FDG) positron emission tomography/computed tomography (PET/CT) scanning to predict …

A phase II study of 3′-deoxy-3′-18F-fluorothymidine PET in the assessment of early response of breast cancer to neoadjuvant chemotherapy: results from ACRIN …

L Kostakoglu, F Duan, MO Idowu… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Our objective was to determine whether early change in standardized uptake values (SUVs)
of 3′ deoxy-3′-18F-fluorothymidine (18F-FLT) using PET with CT could predict pathologic …

TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2–negative …

RM Connolly, JP Leal, MP Goetz, Z Zhang… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Epigenetic modifiers, including the histone deacetylase inhibitor vorinostat, may sensitize
tumors to chemotherapy and enhance outcomes. We conducted a multicenter randomized …

18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer

J Duch, D Fuster, M Muñoz, PL Fernández… - European journal of …, 2009 - Springer
Purpose The aim of this study was to prospectively evaluate 18 F-FDG PET/CT in predicting
response to neoadjuvant chemotherapy in large primary breast cancer. Methods Fifty …